Krystal Biotech's total assets for Q2 2026 were $1.50B, an increase of 7.42% from the previous quarter. DE:4KB total liabilities were $141.52M for the fiscal quarter, a 17.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.